[Preliminary consensus statement on glucocorticoid-induced osteoporosis].
Scharla
S H
SH
Klinikum Berchtesgadener Land, Schönau am Königssee Rheumatologie/Klin. Immunologie, Humboldt-Universität Berlin.
Buttgereit
F
F
Dreher
R
R
Felsenberg
D
D
Franck
H
H
Hein
G
G
Lemmel
E M
EM
Rau
R
R
Sieper
J
J
Braun
J
J
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D015519:Bone Density / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced*; D012307:Risk Factors; D013256:Steroids
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D013256:Steroids